MedTrace Logo

To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study

NCT06918743 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2025-04-09

No results posted yet for this study

Summary

To evaluate the efficacy and safety of RSS0393 ointment in patients with plaque psoriasis Phase II study

Conditions

  • Psoriatic Subjects

Interventions

DRUG

RSS0393 ointment

RSS0393 ointment 0.01%

DRUG

RSS0393 ointment

RSS0393 ointment 0.03%

DRUG

RSS0393 ointment placebo

RSS0393 ointment placebo

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2026-03-31
Completion
2026-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06918743 on ClinicalTrials.gov